Year: 2020

LONDON and NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, will present at the Barclays Gene Editing & Gene Therapy Summit on Monday, November 16, 2020 at 1:30 p.m. ET.A live webcast of the presentation will be available on the Investors page of the Company’s website at www.investors.meiragtx.com. A replay of the webcast will be available for approximately 30 days following the presentation.About MeiraGTxMeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in viral vector design and...

SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that President and CEO Athena Countouriotis, M.D., will present a company overview at the Jefferies Virtual London Healthcare Conference on Nov. 18.Dr. Countouriotis’ session is scheduled to begin at 12:35 p.m. ET and will be accessible via webcast through the Investors page of www.tptherapeutics.com.About Turning Point Therapeutics Inc.Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies. The company’s lead drug candidate, repotrectinib, is a next-generation kinase inhibitor...

EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer is scheduled to present at the Jefferies Virtual London Healthcare Conference.Details of the presentation are as follows:A live webcast of the fireside chat will be available under the “For Investors” section of the Antares Pharma website at www.antarespharma.com.About Antares PharmaAntares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various...

SUNNYVALE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Infinera Corporation (NASDAQ: INFN) announced today that Tom Fallon, Chief Executive Officer, David Heard, Chief Operating Officer, and Nancy Erba, Chief Financial Officer, are scheduled to participate at the Needham Virtual Security, Networking, and Communications Conference and present on Tuesday, November 17, 2020 at 11:00 a.m. Eastern Time.A live webcast, as well as the replay, of these presentations will be accessible from the Investors section of the Infinera’s website at investors.infinera.com and selecting events.Contacts:Media:Anna VueTel. +1 (916) 595-8157avue@infinera.comInvestors:Amitabh Passiapassi@infinera.comMichael Bowen, ICR, Inc.Tel. +1 (203) 682-8299Michael.Bowen@icrinc.comMarc P. Griffin, ICR, Inc.Tel. +1 (646)-277-1290Marc.Griffin@icrinc.comAbout InfineraInfinera...

FOSTER CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced that company management will present at the Jefferies Virtual London Healthcare Conference on Tuesday November 17, 2020 at 12:35pm ET.A live webcast of the presentation can be accessed through the Investors & Media section of the Company’s website at http://investors.vaxcyte.com. A replay of the webcast will be available for approximately 30 days following the conference.About VaxcyteVaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to...

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX: FC) is pleased to announce that it has entered into an agreement to sell, on a bought deal basis, to a syndicate of underwriters bookrun by TD Securities Inc., CIBC Capital Markets and National Bank Financial Inc., 1,860,000 common shares of the Corporation (the “Shares”) at a price of $12.10 per Share (the “Issue Price”) for gross proceeds of $22,506,000. The Corporation has also granted the underwriters an over-allotment option to purchase up to 279,000 Shares at the Issued Price exercisable, in whole or in part, at any time until 30 days following the closing of the offering. If the over-allotment option is exercised in full, the...

SAMPO PLC                        STOCK EXCHANGE RELEASE                                        10 November 2020 at 11:35 pmNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR IN OR INTO ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAWResult of Sampo’s offering of Nordea sharesAs announced on 10 November 2020, Sampo has successfully sold 162 million Nordea shares in an accelerated bookbuild offering to institutional investors.The transaction price was EUR 7.25 per share, resulting in gross proceeds of EUR 1,174 million. Sampo will incur an accounting loss of EUR 222 million from the transaction for the last quarter of 2020.After the transaction, Sampo holds 642,924,782 Nordea shares, corresponding to 15.9 per cent of all shares and voting rights in...

SAMPO OYJ                                              PÖRSSITIEDOTE                                        10.11.2020 klo 23.35TÄTÄ TIEDOTETTA EI SAA JULKAISTA TAI LEVITTÄÄ YHDYSVALLOISSA, AUSTRALIASSA, KANADASSA, JAPANISSA TAI MISSÄÄN MUUSSA SELLAISESSA MAASSA, JOSSA ARVOPAPERIEN TARJOAMINEN TAI MYYMINEN OLISI SOVELTUVAN LAINSÄÄDÄNNÖN MUKAAN KIELLETTYSammon Nordea-osakemyynnin tulosSampo on 10.11.2020 tiedotetun mukaisesti myynyt onnistuneesti 162 miljoonaa Nordean osaketta nopeutetulla tarjousmenettelyllä institutionaalisille sijoittajille.Myyntihinta oli 7,25 euroa osakkeelta ja bruttomyyntitulo 1 174 miljoonaa euroa. Sampo kirjaa myynnistä 222 miljoonan euron kirjanpidollisen tappion vuoden 2020 viimeiselle neljännekselle.Sampo omistaa myynnin jälkeen 642 924 782 Nordean osaketta, mikä vastaa 15,9 prosenttia Nordean kaikista osakkeista...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Summit Industrial Income REIT (“Summit” or the “REIT”) (TSX: SMU.UN) announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets (collectively, the “Underwriters“) to sell, on a bought deal basis, 12,455,000 Units at a price of $13.65 per Unit for gross proceeds to Summit of approximately $170 million (the “Offering”). In addition, Summit has granted the Underwriters an over-allotment option to purchase up to an additional 1,868,250 Units on the same terms and conditions, exercisable at any time, in whole or in part, up to 30 days after the closing of the Offering. The Offering is expected to close on or about November...